G. Vogelsang

发表

Bone marrow transplantation in Shwachman–Diamond syndrome

Jw Hsu, G. Vogelsang, R. Jones, 2002, Bone Marrow Transplantation.

Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?

E. Bass, V. Mock, J. D. Rizzo, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.

G. Akpek, G. Vogelsang, S. M. Lee, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors for post-stem cell transplant sinusitis

G. Vogelsang, A. Thompson, M. Couch, 2002, Bone Marrow Transplantation.

Weight loss and malnutrition in patients with chronic graft-versus-host disease

D. Jacobsohn, G. Vogelsang, V. Anders, 2002, Bone Marrow Transplantation.

Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients.

Richard J. Jones, C. Enger, H. Braine, 1998, Blood.

Thalidomide as replacement for steroids in immunosuppression after lung transplantation.

W. Baumgartner, R. Hruban, P. Gaudin, 1995, The Annals of thoracic surgery.

CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity.

J. Davis, K. Schepers, R. Jones, 1997, Transplantation proceedings.

Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease

D. Jacobsohn, G. Vogelsang, S. Montross, 2001, Bone Marrow Transplantation.

5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens

G. Dover, S. Boyer, S. Charache, 1985 .

An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease.

G. Vogelsang, J. Margolis, 2000, Seminars in oncology.

Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.

G. Hutchins, M. Streiff, H. Tsai, 2001, The hematology journal : the official journal of the European Haematology Association.

Strategies for determining HLA compatibility in related donor bone marrow transplantation.

A. Steinberg, A. Zachary, M. Leffell, 1997, Transplantation.

Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from The Eastern Cooperative Oncology Group (ECOG)

H. Lazarus, J. Rowe, G. Vogelsang, 1997, Bone Marrow Transplantation.

Management of graft-versus-host disease.

G. Vogelsang, S. Arai, G. Vogelsang, 2000, Blood reviews.

Pancreatic insufficiency in patients with chronic graft-versus-host disease

G. Akpek, G. Vogelsang, J. Margolis, 2001, Bone Marrow Transplantation.

CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies

M. Grever, R. Abrams, S. Piantadosi, 1998, Bone Marrow Transplantation.

Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial

R. Abrams, S. Piantadosi, A. Hess, 1999, Bone Marrow Transplantation.

Rapid-onset leucodrema associated with graft-versus-host disease

D. Jacobsohn, K. Ruble, G. Vogelsang, 2002, Bone Marrow Transplantation.

Development of a prognostic model for grading chronic graft-versus-host disease.

S. Piantadosi, M. Zahurak, G. Akpek, 2001, Blood.

Graft versus host disease after blood transfusions in a premature infant.

J. Graeber, A. Funkhouser, B. Zehnbauer, 1991, Pediatrics.

Acute bleeding and thrombocytopenia after bone marrow transplantation

J. George, C. Enger, H. Braine, 2001, Bone Marrow Transplantation.

Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy.

J. Wagner, B. Zehnbauer, C. Griffin, 1992, Bone marrow transplantation.

High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases

D. Jacobsohn, S. Noga, G. Vogelsang, 2003, Bone Marrow Transplantation.

Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir

G. Vogelsang, B. Mookerjee, 1997, Bone Marrow Transplantation.

Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactions

K. Schepers, A. Seber, S. Noga, 1998, Bone Marrow Transplantation.

Chronic graft-versus-host disease.

G. Vogelsang, J. Margolis, 2008, Journal of hematotherapy & stem cell research.

Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings

G. Vogelsang, S. Arai, G. Vogelsang, 2001, Bone Marrow Transplantation.

Advances in the treatment of graft-versus-host disease

G. Vogelsang, 2000, Leukemia.

Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant.

L. Grochow, S. Piantadosi, R. Jones, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thalidomide induction of bone marrow transplantation tolerance.

G. Gordon, A. Hess, G. Santos, 1987, Transplantation proceedings.

Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine.

W. Baumgartner, A. Herskowitz, B. Reitz, 1990, Transplantation.

BMT for severe aplastic anemia using cyclosporine.

E. Mellits, C. Griffin, W. May, 1993, Bone marrow transplantation.

Association between TGF-beta expression and severe GVHD in allogeneic bone marrow transplantation.

A. Zachary, M. Leffell, G. Vogelsang, 2001, Transplantation proceedings.

A case of retroperitoneal fibrosis in a patient following HSCT

A. Nanda, J. D. Rizzo, G. Vogelsang, 2005, Bone Marrow Transplantation.

Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.

L. Morris, A. Hess, P. Ruvolo, 1995, Transplantation proceedings.

Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial

J Wagner, J. Wagner, A. Donnenberg, 1988 .